For Pharmacists: Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma

Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma: Did you know that HER2-targeted therapy is an established treatment option for patients with HER2-positive metastatic gastric/gastroesophageal junction (GEJ) cancer? Credit available for this activity expires: 3/29/25 Earn Credit / Learning Objectives... by Keeping Current CME

29 min listen

Latest Update on HER2-Low Breast Cancer and Implications for Clinical Practice: Did you know that patients with HER2-low metastatic breast cancer now have approved treatment options? Join for a discussion on trial data and testing. Credit available for this activity expires: 12/5/24 Earn Credit / Learning Objectives &... by Keeping Current CME

21 min listen

Managing the Borderline-Risk Patient With Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Shedding Light on the Role of Surgeon, Radiologist, and Oncologist: Do you consult with the multidisciplinary team (MDT) when making treatment decisions for patients with hormone receptor (HR)-positive/HER2-negative early breast cancer (EBC)? Credit available for this activity expires: 11/21/24 Earn Credit / Learning... by Keeping Current CME

28 min listen

Navigating Between Endocrine Therapy, Chemotherapy, and CDK 4/6 Inhibitors for High-Risk HR+/HER2- Early Breast Cancer: The Great Debate: What strategies are you using to individualize treatment of HR+/HER2- early breast cancer? Credit available for this activity expires: 11/17/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

32 min listen

Multidisciplinary Team Best Practices to Improve Adherence for High-Risk, HR-Positive/HER2-Negative Early Breast Cancer: Cases From the Community: What are your strategies to improve adherence in patients with high-risk, HR-positive/HER2-negative early breast cancer? Credit available for this activity expires: 1/9/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

31 min listen

HER2-Positive Metastatic Colorectal Cancer: Unraveling Game-Changing Treatment Approaches: Listen to the experts as they share the latest findings on HER2-directed therapies in the treatment of HER2-positive metastatic colorectal cancer (mCRC). Credit available for this activity expires: 2/28/2025 Earn Credit / Learning... by Keeping Current

36 min listen

Evolution of the Care of Patients With Advanced Ovarian Cancer: Do you know the best way to manage your patients with newly diagnosed advanced ovarian cancer? Credit available for this activity expires: 4/23/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

32 min listen

Navigating the Changing Landscape in Myasthenia Gravis: An Expert Case-Based Discussion: Did you know that new targeted therapies for myasthenia gravis (MG) offer a faster onset of action and improved tolerance in comparison to conventional treatments? Credit available for this activity expires: 14/7/2024 Earn Credit / Learning... by Keeping Current

36 min listen

Understanding the Concerns and Challenges of Patients With HR-Positive/HER2-Negative EBC: Expert Insights and Recommendations: How well do you understand the challenges that patients face with hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negative early breast cancer with a high risk for recurrence? Credit available for this activity expires:... by Keeping Current CME

26 min listen

Expert Exchange: Clinical Implications of the Latest Advances in Metastatic Breast Cancer: Do you know how to personalize treatment for your patients with metastatic breast cancer (mBC)? How can you incorporate emerging treatment strategies? Credit available for this activity expires: 6/12/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

35 min listen

Aditya Bardia, MD, MPH - Navigating the Shifting Treatment Paradigm in ER+/HER2- Breast Cancer: Harnessing Modern Treatment Options and the Expanding Evidence Base to Better Patient Care and Outcomes in Early and Advanced Disease: Go online to PeerView.com/KVE860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. by PeerView Internal Medicine CME/CNE/CPE Audio Podcast

57 min listen

Looking Forward to Thriving With HIV: Interventions to Improve and Maintain Health in People With HIV: Did you know that kindness in the clinic can improve antiretroviral therapy adherence? Credit available for this activity expires: 4/28/2024 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

33 min listen

The Expanding Role of Mutation Testing in Advanced Gastrointestinal Stromal Tumor: From Biology to Therapy Rationale: Did you know that mutational testing helps guide treatment selection in gastrointestinal stromal tumor (GIST)? Listen to learn more! Credit available for this activity expires: 2/9/2025 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

33 min listen

Evolving Paradigms of Hormone Receptor-Positive Breast Cancer: The Rise of Antibody-Drug Conjugates: Are you up to date on the latest clinical trial data on antibody-drug conjugates (ADCs) in hormone receptor (HR)-positive advanced breast cancer? Credit available for this activity expires: 11/20/23 Earn Credit / Learning Objectives &... by Keeping Current

71 min listen

Susana M. Campos, MD, MPH - Expanding the Potential of HER2-Directed Antibody-Drug Conjugates: Evidence and Application in New Tumor Types: Please visit answersincme.com/GXD860 to participate, download slides and supporting materials, complete the post test, and obtain credit. by CME in Minutes: Education in Oncology & Hematology

18 min listen

Sara M. Tolaney, MD, MPH - New Advances and Opportunities for Improvement in HR+/HER2- Early Breast Cancer: Practical Strategies for Optimal Clinical Integration of Adjuvant CDK4 and 6 Inhibitor Therapy: Go online to PeerView.com/AGM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. by PeerView Internal Medicine CME/CNE/CPE Audio Podcast

29 min listen

Immunotherapy in Special Populations With Non-Small Cell Lung Cancer: What Would the Oncologist Do?: Do you know the best way to administer immunotherapy in unique patients with non-small cell lung cancer (NSCLC)? Credit available for this activity expires: 10/27/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

55 min listen

Taking Control of Fertility With Personalized Insights: Leveling the Fertility Care Continuum: Did you know rates of infertility are rising? Learn how clinicians can engage patients in conception counseling. Credit available for this activity expires: 07/03/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

36 min listen

Managing Adverse Events of Novel Antibody-Drug Conjugates in Breast Cancer: Do you know the best practice strategies for preventing and managing adverse events with antibody-drug conjugates (ADCs) in breast cancer? Credit available for this activity expires: 6/27/2024 ... by Keeping Current

19 min listen

Hope S. Rugo, MD, FASCO - Stay in the Know About HER2-Low: Improving Breast Cancer Outcomes with Emerging Antibody Drug Conjugates: Please visit answersincme.com/PHE860 to participate, download slides and supporting materials, complete the post test, and obtain credit. by CME in Minutes: Education in Oncology & Hematology

14 min listen

What's New for the Patient With ER+/HER2- MBC Progressing on CDK 4/6 Inhibitor Therapy? Expert Perspectives on 2023 Updates From San Antonio: Join the experts for recent updates on estrogen receptor-positive (ER+)/HER2-negative (HER2-) metastatic breast cancer (MBC) progressing on cyclin-dependent kinase (CDK) 4/6 inhibitors. Learning Objectives & Disclosures: by Keeping Current

31 min listen

Aditya Bardia, MD - Endocrine Sensitivity in the Real World: Practical Guidance to Optimize Second-Line Care in ER-Positive, HER2-Negative Advanced Breast Cancer: Please visit answersincme.com/GTJ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. by CME in Minutes: Education in Oncology & Hematology

20 min listen

Evolution of Oncogenic-Driven Early-Stage Resectable NSCLC: Testing and Practical Considerations: Are you aware that molecular testing is necessary to inform the appropriate adjuvant treatment decision for patients? Credit available for this activity expires: 3/22/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

38 min listen

Evolving Landscape of HR-Positive Metastatic Breast Cancer: A Year in Review: Join the experts for an in-depth update on hormone receptor (HR)-positive metastatic breast cancer (MBC). Credit available for this activity expires: 3/1/25 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

76 min listen

Geoffrey Ku, MD, MBA - Conversations in Precision Oncology: Harnessing Testing to Drive Personalized Treatment in HER2-Positive Advanced Gastric Cancer: Please visit answersincme.com/DDF860 to participate, download slides and supporting materials, complete the post test, and obtain credit. by CME in Minutes: Education in Oncology & Hematology

14 min listen

Meeting the Experts and Taking Action in Heart Failure: Do you know the latest data and guidelines in patients with heart failure (HF)? Dr Zieroth reviews. Credit available for this activity expires: 6/13/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

23 min listen

Confronting Obesity in Cardiology Care: A Major Driver of Cardiovascular Risk: How can you support your patients living with obesity and cardiovascular (CV) risk? Credit available for this activity expires: 12/18/24 Earn Credit / Learning Objectives & Disclosures: by Keeping Current CME

17 min listen

Stuart J. Schnitt, MD - A New View of the Spectrum of HER2 Expression and Significance of HER2 Low in Breast Cancer: Exploring the Biology and Updating Best Practices for Testing and Treatment: Go online to PeerView.com/NRG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. by PeerView Internal Medicine CME/CNE/CPE Audio Podcast

85 min listen

Understanding the Role of Biologics in Hidradenitis Suppurativa: A Journal Club Review of Recent Data and Clinical Impacts: Are you up to date on the latest clinical trial data on biologic therapy in hidradenitis suppurativa (HS)? Credit available for this activity expires: 10/31/2024 Earn Credit / Learning Objectives & Disclosures: by Keeping Current

32 min listen

Erika Hamilton, MD - Clarifying the Complexities of the Expanding Treatment Options for Advanced- and Early-Stage HR+/HER2- Breast Cancer: Go online to PeerView.com/YNC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. by PeerView Internal Medicine CME/CNE/CPE Audio Podcast

101 min listen

Discover this podcast and so much more

For Pharmacists: Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma

For Pharmacists: Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma

Description

Titles in the series (100)

More Episodes from Keeping Current CME

Related podcast episodes